Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nephosity
AddedFeb 17, 2024
UpdatedJun 18, 2026
Nephosity

Nephosity

Nephosity: Enhancing healthcare workflows with collaborative medical imaging software.

HQ
Santa Monica, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Nephosity, founded with the mission to enhance healthcare workflows through innovative technology, focuses on developing collaborative medical imaging software. Their flagship product, MobileCT Viewer, is an FDA-cleared application that allows for the communication and display of CT, MRI, and X-ray images on the iPad. This tool aims to improve the efficiency and effectiveness of multi-specialty care by enabling healthcare providers to access and share medical images anytime, anywhere.

Notable figures affiliated with Nephosity include its founders and key investors who have a background in healthcare technology and innovation. The company has achieved significant milestones, such as receiving FDA clearance for MobileCT Viewer, which underscores its commitment to regulatory compliance and patient safety. Nephosity's impact lies in its ability to streamline medical imaging workflows, thereby enhancing the quality of care and collaboration among healthcare professionals.

Nephosity - Similar Companies

Nephrosant logo

Nephrosant

InstantRad logo

InstantRad

instantrad.com

Sway Medical logo

Sway Medical

swaymedical.com

nView medical logo

nView medical

nviewmed.com

LifeVoxel.AI logo

LifeVoxel.AI

lifevoxel.com

Net Medical Xpress Solutions logo

Net Medical Xpress Solutions

netmedical.com

Subtle Medical logo

Subtle Medical

subtlemedical.com

Braid Health logo

Braid Health

braid.health

Nerbio logo

Nerbio

nerbio.com

MobileMedTek logo

MobileMedTek

image32 logo

image32

AngioCloud logo

AngioCloud

ChestAi logo

ChestAi

iHealthScreen logo

iHealthScreen

ihealthscreen.org

RadUnity logo

RadUnity

radunity.com

Nephosity - Quick Facts

Who are Nephosity's competitors?

Companies similar to Nephosity include Nephrosant, InstantRad, Sway Medical and nView medical.

When was Nephosity founded?

Nephosity was founded in 2010.

Where is Nephosity's headquarters located?

Nephosity's headquarters is located in Santa Monica, CA, US.

When was Nephosity's last funding round?

Nephosity's most recent funding round was for $20k (USD) in January 2012.

How much has Nephosity raised to-date?

As of Jan 1, 2012, Nephosity has raised a total of $20k (USD).

How many employees does Nephosity have?

Nephosity has 7 employees as of Feb 4, 2024.

Nephosity - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Medical Imaging
  • Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 11 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified